1 / 26

April 2012

Quality Affordable Healthcare Products. Company Overview. April 2012. Contents. Corporate profile Perrigo in the UK Growth strategy for Europe. The Perrigo Company. Overview . ‘L. Perrigo Company’ formed 1887, now publicly owned and listed on NASDAQ and in Israel

nhi
Download Presentation

April 2012

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Quality Affordable Healthcare Products Company Overview April 2012

  2. Contents Corporate profile Perrigo in the UK Growth strategy for Europe

  3. The Perrigo Company

  4. Overview ‘L. Perrigo Company’ formed 1887, now publicly owned and listed on NASDAQ and in Israel World’s largest supplier of ‘Store Brand’ OTC medicines and Nutritional Supplements Also active in specialist prescription medicines, active pharmaceutical ingredients (api’s) and infant nutrition products Turnover >$2.5 billion

  5. Perrigo’s HeadquartersAllegan, Michigan, USA R&D Tablet Packaging Print & Marketing Liquids Manufacturing Administrative Offices

  6. International Presence Products distributed worldwide Operations in: USA Canada Mexico UK Israel China India Australia

  7. Perrigo in the UK

  8. UK Business Overview UK’s largest supplier of Private Label OTC medicines Contract manufacturer for a number of leading international branded pharma and healthcare companies Operating in 2 locations: Braunton, Devon and Barnsley, South Yorkshire Annual Turnover ~ £80M 490 employees

  9. Capabilities

  10. Manufacturing Solid Dose Liquid Dose Tablets Creams Caplets Ointments Capsules Liquids Powders Hot Melts – Supps Balms Syrups Suspensions Gels

  11. Packing Solid Dose Liquid Dose Blisters Tubes Sachets Bottles Roll Wraps Tubs Tubs Form Sealing

  12. Annual Sales Volumes 20 Million Bottles & Tubes 65 Million Sachets 5 Billion Tablets 500 Million Capsules > 750 Sku’s

  13. Products & Therapeutic Areas

  14. Products • Analgesics • Cough, Cold & Flu • Hayfever & Allergy • Gastrointestinal • Nicotine Replacement Therapy • Antifungals • Diagnostic Tests • Sleeping Aids • Female Health • Hair Care Over 130 product licences Active in all major OTC therapeutic areas:

  15. Some of our Existing Partners

  16. Private Label Customers

  17. Business-To-Business Customers

  18. Innovation

  19. Creating Value Through Innovation • Development and Regulatory expertise • New products • Developed in-house • In-licenced • Regulatory initiatives – licencing strategies and switches • Industry leader in switches • More ARM’s granted than any other company • Approx 12% of all ARM’s

  20. Examples Internally Developed Registrations: • Cough & Cold Sachet (Para, Phenylephrine, Guaifenesin) • Cough & Cold Tablet (Para, Phenylephrine, Guaifenesin) • Ibuprofen Lysine Tablets 342mg • Phenylephrine Capsules 12.2mg • Max Strength Day & Night Cold & Flu Capsules Switches: • First antibiotic POM to P (Chloramphenicol) • First topical steroid P to GSL (Hydrocortisone) • First eye drops P to GSL (Sodium Cromoglycate) • Flu All In One Liquid P to GSL (Paracetamol, Phenylephrine, Guaifenesin, CPC) • First oral analgesic POM to P switch for ~ 20 years(Naproxen)

  21. Success

  22. Our Success is Built on... • High Quality • Independently Approved by: MHRA, GMP, BSi ISO 9001:2008 & ISO 13485:2003 • BRC Global standard Consumer Products and Investor in People • Committed to social & ethical practices and the ETI base code (Ethical Trading Initiative) • Excellent Service • ‘Supplier of the year’ awards – GSK & Tesco • ‘Best Process Factory’ award - Management Today magazine • Low Cost • Global buying power and Manufacturing efficiencies • Innovative Products • Significant investment into NPD • Building Long Term Business Relationships • Work with a few select partners

  23. Growth Strategy Europe

  24. Perrigo European Growth Strategy • Corporate strategy to grow Perrigo’s presence in Europe • Register a wide range of products in key European markets • Therapeutic areas include: • Analgesics • Gastrointestinal remedies • Nicotine-replacement therapy products • Cough & cold • Allergy relief

  25. Contact Information New Business Project Enquiries • Telephone: + 44 (0) 1271 818 925 • Email: sales@perrigouk.com General Enquiries Perrigo - Braunton: • Telephone: + 44 (0) 1271 815 815 • Email: enquiriesbraunton@perrigouk.com Perrigo - Barnsley: • Telephone: + 44 (0) 1226 779911 • Email: enquiriesbarnsley@perrigouk.com

More Related